News

Playtika Holding Corp. Delivers Solid Financial Performance

Playtika Holding Corp. Delivers Solid Financial Performance

Key Financial Highlights from Playtika Holding Corp.

Playtika Holding Corp. (NASDAQ: PLTK) has achieved remarkable financial results for its most recent quarter. The company reported a total revenue of $620.8 million, which reflects a slight decrease of 1.0% from the previous quarter and a 1.5% decline year-over-year. Despite these numbers, Playtika’s Direct-to-Consumer (DTC) revenue was impressive, reaching $174.4 million, which showcases a sequential increase of 0.4% and an annual growth of 8.3%.

Net Income and EBITDA Performance

The net income for the quarter stood at $39.3 million, representing a significant decline of 54.6% sequentially yet an increase of 3.7% compared to the same quarter last year. The Credit Adjusted EBITDA was reported at $197.2 million, which marked a sequential increase of 3.2% but a 4.1% decline compared to the same period last year.

Company's Liquidity and Capital Allocation

As of September 30, 2024, Playtika maintained a strong liquidity position, with cash, cash equivalents, and short-term investments totaling $1.2 billion. This solid financial base provides the company with the flexibility to pursue its growth strategies and manage its capital allocation effectively.

Strategic Acquisition Plans

CEO Robert Antokol shared his excitement regarding the acquisition of SuperPlay, stating that it is poised to enhance Playtika's offerings. This strategic move not only aligns with the company’s growth strategy but is expected to nurture the gaming experience for existing players while providing significant value to shareholders.

Gaming Metrics and Innovations

The operational metrics paint a positive picture for Playtika. The company reported an Average Daily Paying User (DPU) of 301K, which reflects a 1.0% sequential increase and 0.7% year-over-year growth. The Average Payer Conversion increased to 4.0%, up from 3.7% in Q2 and 3.6% in Q3 of the previous year. This indicates that Playtika’s strategies to deepen player engagement are proving effective.

Performance of Key Titles

Among Playtika's top three gaming titles, revenue growth was notable. Bingo Blitz led the way with revenue of $159.9 million, reflecting a 2.7% increase sequentially and a 6.8% rise year-over-year. However, Solitaire Grand Harvest and Slotomania showed varied results, with revenues of $79 million and $128.7 million respectively. While Solitaire Grand Harvest grew 6.5% sequentially, Slotomania faced a decline of 3.8%.

Quarterly Dividend Announcement

In a show of confidence in its financial health, Playtika’s Board of Directors declared a cash dividend of $0.10 per share for common stockholders. This dividend is scheduled to be paid on January 3, 2025, to all stockholders recorded by December 20, 2024. Such decisions reflect the company’s commitment to returning value to its investors.

Forward Outlook and Guidance

Looking ahead, Playtika has updated its revenue guidance for the full year 2024 to a range of $2.505 billion to $2.520 billion. Furthermore, the company has raised its Credit Adjusted EBITDA guidance to between $755 million and $765 million while reducing its capital expenditure outlook to $90 million. This proactive adjustment showcases the firm’s readiness to adapt to changing market conditions.

Management Conference Call Insights

Playtika management will host a conference call to discuss these results in depth, allowing investors and interested parties to engage directly with leadership about the company’s direction and strategic initiatives.

About Playtika Holding Corp.

Founded in 2010, Playtika has established itself as a mobile gaming entertainment leader, known for its diverse gaming portfolio. Headquartered in Herzliya, Israel, Playtika embraces its mission to entertain through innovative gaming experiences, with operations spanning across multiple international offices.

Frequently Asked Questions

What were Playtika’s total revenues for Q3 2024?

Playtika reported total revenues of $620.8 million for Q3 2024.

How did the Direct-to-Consumer revenue perform?

The Direct-to-Consumer (DTC) revenue was $174.4 million, increasing by 0.4% sequentially and 8.3% year-over-year.

What is the expected revenue range for the full year 2024?

For the full year 2024, Playtika expects the revenue to be in the range of $2.505 billion to $2.520 billion.

When is the next dividend scheduled to be paid?

The next cash dividend is scheduled to be paid on January 3, 2025, with a rate of $0.10 per share.

How does Playtika define Credit Adjusted EBITDA?

Credit Adjusted EBITDA is defined as net income before interest expense, interest income, provision for income taxes, depreciation and amortization expense, impairment charges, stock-based compensation, and other related costs.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Celebree Gains Franchise Momentum: A New Frontier

Updated Category News Views 9

The Climb: Celebree Schools on the Rise Here's a nugget in the franchise world that's causing a stir: Celebree School is making moves up the Franchise Times Top 400. When we're talking about a hop, skip, and jump through 84 spots since 2023, you can't help but notice. It's the third year in a row they're climbing this ladder, and it's making ripples. Franchise Expansion...

Continue Reading
New American Funding Expands in Carolinas with Mullinix Move

Updated Category News Views 11

The Gathering of Mortgage Titans You don't just waltz into the mortgage world with a $2 billion track record and expect folks not to notice. Will Mullinix, a name that's become synonymous in the Carolinas with mortgage mastery, has decided to bring his influential Mullinix Mortgage Group under the banner of New American Funding. Talk about a power play. This bold strategy...

Continue Reading
CMC Declares Dividend Amid Complex Outlook

Updated Category News Views 12

Dividend's Not Just a Regular Check October 13, 2026, marks yet another dividend declaration by CMC. This time, they're dishing out $0.20 per share—a steady payday for loyal shareholders. That's 248 times in a row they've done this song and dance. Odds are, folks holding NYSE:CMC shares are giving the nod of approval, but it ain't just about cash; it's about stability...

Continue Reading
VetsinTech's AI Training Boosts Military Careers

Updated Category News Views 21

A New Spin on Engineering Careers Sometimes it feels like every corner I turn in this market maze, there’s something about AI. It’s not just chirping in the tech world anymore; it’s banging on the doors of sectors like engineering, aerospace, and manufacturing. And now, VetsinTech is tossing its hat into the AI ring with a fresh program aimed at blending military...

Continue Reading
Think Tank Pushes for Bold Parkinson's Prevention Plan

Updated Category News Views 14

A New Era for Parkinson's Disease Prevention The Parkinson's Foundation has rolled out its battle plan to take on Parkinson's disease from the ground up, shifting gears from managing symptoms to stopping the illness before it starts. It's about damn time, too. With the disease being the fastest-growing neurodegenerative disorder and impacting 10 million people worldwide,...

Continue Reading
Montessori and Tech: A New Era of Integration

Updated Category News Views 13

Reimagining Montessori with Technology Let's take a stroll down the road less traveled—the intersection of Montessori education and tech. For over a century, Montessori schools have valued individual child development, autonomy, and a purpose-driven environment. But let's face it, their technology hasn't always had the same handcrafted finesse. That's where illumine...

Continue Reading
Veterans Transitioning to Real Estate with Scholarships

Updated Category News Views 10

Tapping Military Skills for Civilian Gain Finding a new career after military service is a mountain of a task, but veterans now have a golden ticket into the real estate appraisal world. The Appraisal Institute's Next Mission Scholarship is throwing veterans a $1,000 life preserver to dive into a field where their military-honed skills already shine. The Power of a...

Continue Reading
TechCrunch Disrupt 2026: NYSE and Snowflake Highlights

Updated Category News Views 12

Ever noticed how the air vibrates just a bit more when major players like NYSE and Snowflake start shaking hands at big-league events like TechCrunch Disrupt? You'd better believe we're seeing a fresh brew of opportunities and challenges in the market as these titans lock horns and share insights. It's no small feat when the financial nerve center partners into the tech...

Continue Reading
Quark Baby's Milk Warmer Debut at Vancouver & Dubai

Updated Category News Views 10

An Unconventional Pitch for Baby Gear Quark Baby is strutting its stuff not just in Vancouver but all the way in Dubai. Yeah, we're talking about a milk warmer hitting two major expos. What's the deal with an award-winning brand from Vancouver making so much noise? From October 17-18, they're home-court at The Baby Show Vancouver, and by October 22-24, they're in Dubai at...

Continue Reading
OmniActive's Fenavari: A New Era in Women's Health

Updated Category News Views 16

Pioneering Women's Health with Fenavari You ever wonder why some health products get all the hype? Here's one for the book: OmniActive Health Technologies launching Fenavari, their top-tier contender in the women's health market. Now, we're not talking your run-of-the-mill supplement here. We're stepping onto a new playing field, especially with Dr. Taz Bhatia stepping...

Continue Reading

Top 5 Most Recently Viewed Articles

Belmont Medical Technologies Welcomes Brian Larkin as New CEO

Updated Category News Views 223

Belmont Medical Technologies Appoints Brian Larkin as CEO Belmont Medical Technologies, renowned for its advanced fluid resuscitation and patient temperature management systems, has made a significant leadership change. Brian Larkin has stepped into the role of Chief Executive Officer, succeeding Brian Ellacott, effective immediately. A respected figure within the medical...

Continue Reading
Elanco Animal Health's Q3 2024 Financial Overview and Insights

Updated Category News Views 75

Elanco Animal Health Q3 2024 Financial Results Elanco Animal Health Incorporated (NYSE: ELAN) recently announced its financial performance for the third quarter of 2024. The revenue for this period reached $1,030 million, reflecting a 4% decrease on a reported basis. However, when adjusted for the impacts of the aqua business divestiture and foreign exchange fluctuations,...

Continue Reading
NetraMark Host Conference Call to Discuss Growth Strategies

Updated Category News Views 142

NetraMark Holdings Inc. Plans Shareholder Conference Call NetraMark Holdings Inc. (CSE: AIAI) (OTCQB: AINMF) is preparing to host a shareholder conference call where they aim to discuss their recent achievements and exciting opportunities. As a leading company in artificial intelligence, NetraMark is transforming the pharmaceutical industry by utilizing AI-powered...

Continue Reading
Annovis Bio to Share Insights on Dementia and Innovative Treatment

Updated Category News Views 70

Annovis Bio's Involvement in Dementia Research Workshops In a significant step towards advancing treatment for neurodegenerative diseases, Annovis Bio Inc. (NYSE: ANVS) has announced that its President and CEO, Dr. Maria Maccecchini, is set to present at a national workshop focused on Dementia with Lewy Bodies (DLB). This event, which will take place online, is sponsored...

Continue Reading
Strategic Acquisition Fuels Growth for SP Manufacturing

Updated Category News Views 205

SP Manufacturing Partners with Ideal Jacobs to Enhance Capabilities SP Manufacturing (SPM), a prominent name in the field of Electronics Manufacturing Services (EMS), has made significant strides by acquiring the operations of Ideal Jacobs (IJA) in Asia. This strategic move is set to bolster SPM's capabilities to serve mission-critical industries, opening doors to new...

Continue Reading